Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.475
+0.025 (1.72%)
Mar 4, 2026, 2:48 PM EST - Market open

Lucid Diagnostics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
47.3322.3618.922.4753.660.11
Cash & Short-Term Investments
47.3322.3618.922.4753.660.11
Cash Growth
226.68%18.32%-15.92%-58.12%48238.74%-29.03%
Accounts Receivable
0.550.050.050.020.2-
Inventory
0.490.340.280.11--
Other Current Assets
1.472.42.851.753.451.33
Total Current Assets
49.8425.1522.0724.3657.31.44
Net Property, Plant & Equipment
2.883.72.643.60.97-
Other Intangible Assets
0.420.741.423.45--
Other Long-Term Assets
0.051.131.131.110.730.76
Total Assets
53.230.7227.2732.51592.2
Accounts Payable
0.751.241.151.061.492.06
Accrued Expenses
2.282.833.841.451.110.39
Short-Term Debt
22.318.613.95---
Current Portion of Leases
0.880.851.110.96--
Other Current Liabilities
--9.344.961.6613.26
Total Current Liabilities
26.2123.5229.388.434.2615.71
Long-Term Leases
1.161.80.21.04--
Total Long-Term Liabilities
1.161.80.21.04--
Total Liabilities
27.3625.3229.589.464.2615.71
Preferred Stock
54.2754.4218.63---
Common Stock
0.130.060.040.040.040.01
Additional Paid-in Capital
229.5154.68129.76121.0896.610.29
Retained Earnings
-258.07-203.77-150.74-98.08-41.9-13.83
Shareholders' Equity
25.845.39-2.3123.0554.74-13.52
Total Liabilities & Equity
53.230.7227.2732.51592.2
Total Debt
24.3421.2515.26200
Net Cash (Debt)
231.13.6420.4853.660.11
Net Cash Growth
1983.06%-69.68%-82.22%-61.84%48238.74%-29.03%
Net Cash Per Share
0.270.020.070.332002.860.01
Book Value
25.845.39-2.3123.0554.74-13.52
Book Value Per Share
0.300.09-0.050.372043.28-0.67
Tangible Book Value
25.414.66-3.7419.654.74-13.52
Tangible Book Value Per Share
0.290.08-0.070.312043.28-0.67
Updated Nov 12, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q